Ann Rehabil Med.  2012 Oct;36(5):675-680.

Extracorporeal Shock Wave Therapy in Myofascial Pain Syndrome of Upper Trapezius

• Ji HM
• Kim HJ
• Han SJ

Abstract

OBJECTIVE
To evaluate the effect of extracorporeal shock wave therapy (ESWT) in myofascial pain syndrome of upper trapezius with visual analogue scale (VAS) and pressure threshold by digital algometer. METHOD: Twenty-two patients diagnosed with myofascial pain syndrome in upper trapezius were selected. They were assigned to treatment and standard care (control) groups balanced by age and sex, with eleven subjects in each group. The treated group had done four sessions of ESWT (0.056 mJ/mm2, 1,000 impulses, semiweekly) while the control group was treated by the same protocol but with different energy levels applied, 0.001 mJ/mm2. The VAS and pressure threshold were measured twice: before and after last therapy. We evaluated VAS of patients and measured the pressure threshold by using algometer.
RESULTS
There were two withdrawals and the remaining 20 patients were three men and 17 women. Age was distributed with 11 patients in their twenties and 9 over 30 years old. There was no significant difference of age, sex, pre-VAS and pre-pressure threshold between 2 groups (p>0.05) found. The VAS significantly decreased from 4.91+/-1.76 to 2.27+/-1.27 in the treated group (p<0.01). The control group did not show any significant changes of VAS score. The pressure threshold significantly increased from 40.4+/-9.94 N to 61.2+/-12.16 N in the treated group (p<0.05), but there was no significant change in the control group.
CONCLUSION
ESWT in myofascial pain syndrome of upper trapezius is effective to relieve pain after four times therapies in two weeks. But further study will be required with more patients, a broader age range and more males.

Keyword

Extracorporeal shock wave therapy; Myofascial pain syndrome; Upper trapezius; Visual analogue scale; Pressure threshold

MeSH Terms

Female
Humans
Male
Myofascial Pain Syndromes
Shock

Figure

• 

  Fig. 1 Comparison of VAS. The VAS significantly decreased in treated group but control group didn't change significantly. *p<0.05 by Wilcoxon Signed Ranks test. Comparing between two groups, there is significant change of VAS only in treated group. †p<0.05 by Mann-Whitney test.

• 

  Fig. 2 Comparison of pressure threshold. The pressure threshold significantly increased in treated group but control group didn't change. *p<0.05 by Wilcoxon Signed Ranks test. There is significant change of pressure threshold only in treated group. †p<0.05 by Mann-Whitney test.

Reference

1. Sciotti VM, Mittak VL, DiMarco L, Ford LM, Plezbert J, Santipadri E, Wigglesworth J, Ball K. Clinical precision of myofascial trigger point location in the trapezius muscle. Pain. 2001; 93:259–266. PMID: 11514085.

2. Wade B. Trigger points in the upper trapezius or normal subtrapezial anatomy? Physiother Can. 2001; 53:219–222.

3. Fischer AA. Pressure algometry over normal muscles. Standard valuses, validity and reproducibility of pressure threshold. Pain. 1987; 30:115–126. PMID: 3614975.

4. Simons DG, Travell JG, Simons LS. Myofascial pain and dysfunction: upper half of body. 1999. 2nd ed. Baltimore: Lippincott Williams & Wilkins;p. 69–86.

5. Borg-Stein J, Simons DG. Focused review: myofascial pain. Arch Phys Med Rehabil. 2002; 83:S40–S47. PMID: 11973695.

6. Bennet R. Myofascial pain syndromes and their evaluation. Best Pract Clin Rheumatol. 2007; 21:427–445.

7. De las Penas CF, Campo MS, Carnero JF, Miangolarra Page JC. Manual therapies in myofascial trigger point treatment: a systematic review. J Bodyw Mov Ther. 2005; 9:27–34.

8. Rickards LD. The effectiveness of non-invasive treatments for active myofascial trigger point pain: a systematic review of the literature. Int J Osteopath Med. 2006; 9:120–136.

9. Simons DG. Myofascial pain and dysfunction syndrome. J Muscoskel Pain. 1993; 1:123–132.

10. Tough EA, White AR, Cummings TM, Richards SH, Campbell JL. Acupuncture and dry needling in the management of myofascial trigger point pain: a systematic review and meta-analysis of randomized controlled trials. Eur J Pain. 2009; 13:3–10. PMID: 18395479.

11. Müller-Ehrenberg H, Licht G. Diagnosis and therapy of myofascial pain syndrome with focused shock waves (ESWT). Med Orthop Tech. 2005; 5:1–6.

12. Bauermeister W. Diagnosis and therapy of myofascial trigger point syndrome through stimulation of sensitized nociceptors using focused electrohydraulic shockwaves. Med Orthop Tech. 2005; 5:65–74.

13. Liang HW, Wang TG, Chen WS, Hou SM. Thinner plantar fascia predicts decreased pain after extracorporeal shock wave therapy. Clin Orthop Relat Res. 2007; 460:219–225. PMID: 17353798.

14. Hammer DS, Adam F, Kreutz A, Rupp S, Kohn D, Seil R. Ultrasonographic evaluation at 6-month follow-up of plantar fasciitis after extracorporeal shock wave therapy. Arch Orthop Trauma Surg. 2005; 125:6–9. PMID: 14530990.

15. Wang FS, Yang KD, Chen RF, Wang CJ, Sheen-Chen SM. Extracoporeal shock wave promotes growth and differentiation of bone-marrow stromal cells towards osteoprogenitors associated with induction of TGF-beta1. J Bone Joint Surg Br. 2002; 84:457–461. PMID: 12002511.

16. Shah JP, Danoff JV, Desai MJ, Parikh S, Nakamura LY, Phillips TM, Gerber LH. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil. 2008; 89:16–23. PMID: 18164325.

17. Ottomann C, Hartmann B, Tyler J, Maier H, Thiele R, Schaden W, Stojadinovic A. Prospective randomized trial of accelerated re-epithelization of skin graft donor sites using extracorporeal shock wave therapy. J Am Coll Surg. 2010; 211:361–367. PMID: 20800193.

18. Rompe JD, Hope C, Küllmer K, Heine J, Bürger R. Analgesic effect of extracorporeal shock-wave therapy on chronic tennis elbow. J Bone Joint Surg Br. 1996; 78:233–237. PMID: 8666632.

19. Han TR, Kim JH, Paik NJ, Lim SJ. Importance of local twitch response induced by needling in myofascial pain syndrome. J Korean Acad Rehabil Med. 1999; 23:595–600.

20. Rompe JD, Meuer A, Nafe B, Hofmann A, Gerdesmeyer L. Repetitive low-energy shock wave application without local anesthesia is more efficient than repetitive low-energy shock wave application with local anesthesia in the treatment of chronic plantar fascitits. J Orthop Res. 2005; 23:931–941. PMID: 16023010.

21. Shah JP, Gilliams EA. Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome. J Bodyw Mov Ther. 2008; 12:371–384. PMID: 19083696.